Germany-based Inovedis, a medical startup that provides innovative solutions to optimise patient care and minimise the complexity of surgical intervention, announced that it closed a Series A round of funding at €3.78M.
The funding round was participated by Inovedis’ entire initial seed round investors, including High-Tech Gründerfonds, MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg, Volksbank Albstadt ChancenKapital, Start-UP BW Innovation Fonds, and angel investors, and an initial investment by Renolit SE, the current manufacturer of the SINEFIX implant.
Inovedis says it will use the funding to support the commercial launch of the SINEFIX implant system in the United States. The start-up will also use the fund to sponsor a clinical study in Germany to create data necessary to support CE marking and sales expansion into Europe.
About Inovedis
Trauma and orthopaedic surgeon Dr Stefan Welte and entrepreneur Lukas Floess founded Inovedis in 2019. Based in Albstadt, Germany, Inovedis aims to provide medical solutions to create optimised patient care and reduce time and cost in the healthcare sector.
